NCPA

Pharmacy Groups Unite to Fight PBMs in Landmark Supreme Court Case

0 comment(s)
Seal of the Supreme Court of the United States

ALEXANDRIA, Va. (Feb. 21, 2020) - The National Community Pharmacists Association (NCPA) and the Arkansas Pharmacists Association (APA), along with the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA), announced today they will file an amicus curiae brief with the Supreme Court of the United States in support of a case that pits pharmacy benefit managers (PBM) against neighborhood healthcare providers.

Three Pharmacy Associations Ask FDA to Extend Comment Period for GFI #256

0 comment(s)

On February 3, 2020, the American Pharmacists Association, the Alliance for Pharmacy Compounding, and the National Community Pharmacists Association sent this letter to the FDA:

Dockets Management Food and Drug Administration 
5630 Fishers Lane, Rm 1061 
Rockville, MD 20852
 
RE: FDA-2018-D-4533
 
To Whom It May Concern:
 

NCPA Supports House Bill Strengthening Patient Access to Compounded Medications

0 comment(s)
ALEXANDRIA, Va. (June 21, 2017) National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in support of new compounding legislation, H.R. 2871, The Preserving Patient Access to Compounded Medications Act of 2017, introduced by Reps. Morgan Griffith (R-Va.) and Henry Cuellar (D-Texas), that will improve patient access to compounded medications: